EFFICACY OF THE COMPLEMENT INHIBITOR ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS NEVER TRANSFUSED

被引：0
|
作者：
Risitano, A. [1 ]
Alfinito, F. [1 ]
Seneca, E. [1 ]
Marando, L. [1 ]
Boschetti, C. [2 ]
Bonfigli, S. [3 ]
Fenu, S. [4 ]
Re, F. [5 ]
Gosetti, G. [6 ]
Khursigara, G.
Rother, R.
Zanella, A. [2 ]
Rotoli, B. [1 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
[2] Osped Policlin Maggiore, IRCCS, Milan, Italy
[3] Univ Sassari, I-07100 Sassari, Italy
[4] S Giovanni Addolorata Hosp, Rome, Italy
[5] Univ Parma, I-43100 Parma, Italy
[6] Santa Chiara Hosp, Trento, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0581
引用
收藏
页码：237 / 237
页数：1
相关论文
共 50 条
  • [1] The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Young, Neal S.
    Schubert, Joerg
    Brodsky, Robert A.
    Socie, Gerard
    Muus, Petra
    Roeth, Alexander
    Szer, Jeffrey
    Elebute, Modupe O.
    Nakamura, Ryotaro
    Browne, Paul
    Risitano, Antonio M.
    Hill, Anita
    Schrezenmeier, Hubert
    Fu, Chieh-Lin
    Maciejewski, Jaroslaw
    Rollins, Scott A.
    Mojcik, Christopher F.
    Rother, Russell P.
    Luzzatto, Lucio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12): : 1233 - 1243
  • [2] Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Muus, Petra
    Duhrsen, Ulrich
    Risitano, Antonio M.
    Schubert, Jorg
    Luzzatto, Lucio
    Schrezenmeier, Hubert
    Szer, Jeffrey
    Brodsky, Robert A.
    Hill, Anita
    Socie, Gerard
    Bessler, Monica
    Rollins, Scott A.
    Bell, Leonard
    Rother, Russell P.
    Young, Neal S.
    [J]. BLOOD, 2007, 110 (12) : 4123 - 4128
  • [3] Theterminal complement inhibitor eculizumab reduces thrombosis in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, P.
    Muus, P.
    Duehrsen, U.
    Risitano, A.
    Schubert, J.
    Young, N. S.
    Schrezenmeier, H.
    Szer, J.
    Brodsky, R. A.
    Hill, A.
    Socie, G.
    Bessler, M.
    Rollins, S. A.
    Rother, R. P.
    Bell, L.
    Luzzatto, L.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 138 - 138
  • [4] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Rother, Russell P.
    Rollins, Scott A.
    Mojcik, Christopher F.
    Brodsky, Robert A.
    Bell, Leonard
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (11) : 1256 - 1264
  • [5] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Russell P Rother
    Scott A Rollins
    Christopher F Mojcik
    Robert A Brodsky
    Leonard Bell
    [J]. Nature Biotechnology, 2007, 25 : 1256 - 1264
  • [6] The terminal complement inhibitor eculizumab reduces thrombosis in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen, Peter
    Muus, Petra
    Duehrsen, Ulrich
    Risitano, Antonio M.
    Schubert, Joerg
    Young, Neal S.
    Schrezenmeier, Hubert
    Szer, Jeffrey
    Brodsky, Robert A.
    Hill, Anita
    Socie, Gerard
    Rollins, Scott A.
    Rother, Russell P.
    Bell, Leonard
    Luzzatto, Lucio
    [J]. BLOOD, 2006, 108 (11) : 40A - 41A
  • [7] Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial
    Yuzuru Kanakura
    Kazuma Ohyashiki
    Tsutomu Shichishima
    Shinichiro Okamoto
    Kiyoshi Ando
    Haruhiko Ninomiya
    Tatsuya Kawaguchi
    Shinji Nakao
    Hideki Nakakuma
    Jun-ichi Nishimura
    Taroh Kinoshita
    Camille L. Bedrosian
    Marye Ellen Valentine
    Gus Khursigara
    Keiya Ozawa
    Mitsuhiro Omine
    [J]. International Journal of Hematology, 2011, 93 : 36 - 46
  • [8] Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial
    Kanakura, Yuzuru
    Ohyashiki, Kazuma
    Shichishima, Tsutomu
    Okamoto, Shinichiro
    Ando, Kiyoshi
    Ninomiya, Haruhiko
    Kawaguchi, Tatsuya
    Nakao, Shinji
    Nakakuma, Hideki
    Nishimura, Jun-ichi
    Kinoshita, Taroh
    Bedrosian, Camille L.
    Valentine, Marye Ellen
    Khursigara, Gus
    Ozawa, Keiya
    Omine, Mitsuhiro
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (01) : 36 - 46
  • [9] Clinical Impact of Unregulated Terminal Complement Activity in Never-Transfused Patients with Paroxysmal Nocturnal Hemoglobinuria
    Muus, Petra
    Risitano, Antonio M.
    Castro-Malaspina, H. R.
    Jones, C. Michael
    Fuller, Stephen
    Socie, Gerard
    [J]. BLOOD, 2009, 114 (22) : 1546 - 1546
  • [10] Erratum: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Russell P Rother
    Scott A Rollins
    Christopher F Mojcik
    Robert A Brodsky
    Leonard Bell
    [J]. Nature Biotechnology, 2007, 25 : 1488 - 1488
12345